Search
Sonlicromanol
go.drugbank.com/drugs/DB16333InvestigationalSonlicromanol is under investigation in clinical trial NCT04165239 (The KHENERGYZE Study).
Categories: Compounds used in a research, industrial, or household settingRostaporfin
go.drugbank.com/drugs/DB06659InvestigationalCategories: Heterocyclic Compounds with 4 or More RingsDansylamide
go.drugbank.com/drugs/DB02866ExperimentalCategories: Compounds used in a research, industrial, or household settingLerodalcibep
go.drugbank.com/drugs/DB19071ApprovedInvestigational[L54738] PCSK9 is a protein that binds to and promotes the degradation of low-density lipoprotein receptors (LDLRs), which are expressed on hepatocytes regulates circulating LDL levels. … [A275273] Lerodalcibep prevents the actions of PCSK9 and allows more LDL to bind to LDLR and be cleared from circulation.
Clomethiazole
go.drugbank.com/drugs/DB06470InvestigationalIt is a sedative and hypnotic that is widely used in treating and preventing symptoms of acute alcohol withdrawal. … It is also used for the management of agitation, restlessness, short-term insomnia and Parkinson's disease in the elderly.
Categories: Compounds used in a research, industrial, or household settingZomepirac
go.drugbank.com/drugs/DB04828ApprovedWithdrawnZomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions. The manufacturer voluntarily removed Zomax tablets from the Canadian, US, and UK markets in March 1983.
Chelerythrine
go.drugbank.com/drugs/DB17024ExperimentalA benzophenanthridine alkaloid evaluated as a kinase-inhibitor.
Categories: Heterocyclic Compounds with 4 or More RingsAlphaprodine
go.drugbank.com/drugs/DB13160ExperimentalIllicitCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeNalfurafine
go.drugbank.com/drugs/DB13471InvestigationalCategories: Heterocyclic Compounds with 4 or More Rings